Activated factor XI and tissue factor in chronic obstructive pulmonary disease: links with inflammation and thrombin generation (Q34590212)

3 August 2017

Activated factor XI and tissue factor in chronic obstructive pulmonary disease: links with inflammation and thrombin generation (English)

1 reference

chronic obstructive pulmonary disease

3 August 2017

1 reference

2

Anetta Undas

1 reference

3 August 2017

Milosz Jankowski

1

1 reference

PubMed ID

21236471

3 August 2017

Przemyslaw Kaczmarek

series ordinal

3

1 reference

PubMed ID

21236471

3 August 2017

Saulius Butenas

series ordinal

4

1 reference

3 August 2017

13 January 2011

1 reference

3 August 2017

1 reference

3 August 2017

127

1 reference

3 August 2017

242-246

1 reference

3 August 2017

3

1 reference

Activated factor XI and tissue factor in inflammatory bowel disease

3 August 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3042502

Tissue factor in coagulation: Which? Where? When?

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3042502

Circulating tissue factor procoagulant activity is elevated in stable moderate to severe chronic obstructive pulmonary disease

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3042502

Tissue factor activity and function in blood coagulation

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3042502

Mortality in COPD: Role of comorbidities.

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3042502

Tissue factor in cardiovascular diseases: molecular mechanisms and clinical implications

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3042502

Inactivation of factor XIa by plasma protease inhibitors: predominant role of alpha 1-protease inhibitor and protective effect of high molecular weight kininogen

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3042502

Fibrin clot properties are altered in patients with chronic obstructive pulmonary disease. Beneficial effects of simvastatin treatment.

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3042502

Assessment of plasma tissue factor activity in patients presenting with coronary artery disease: limitations of a commercial assay.

27 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3042502

Factor XI in haemostasis and thrombosis: past, present and future.

27 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3042502

Why are patients with chronic obstructive pulmonary disease at increased risk of cardiovascular diseases? The potential role of systemic inflammation in chronic obstructive pulmonary disease.

27 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3042502

Elevated numbers of tissue-factor exposing microparticles correlate with components of the metabolic syndrome in uncomplicated type 2 diabetes mellitus

27 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3042502

Blood coagulation in hemophilia A and hemophilia C.

27 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3042502

Hypercoagulability state in patients with chronic obstructive pulmonary disease. Chronic Obstructive Bronchitis and Haemostasis Group

27 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3042502

Elevated plasma procoagulant and fibrinolytic markers in patients with chronic obstructive pulmonary disease

27 October 2018

1 reference

12 December 2020

Arthritis is linked to local and systemic activation of coagulation and fibrinolysis pathways

1 reference

12 December 2020

Tissue factor activity in whole blood

1 reference

12 December 2020

Immunologic quantitation of tissue factors

1 reference

12 December 2020

Elevated factor XI activity levels are associated with an increased odds ratio for cerebrovascular events

1 reference

12 December 2020

Systemic inflammation in patients with COPD and pulmonary hypertension

1 reference

12 December 2020

Global Strategy for the Diagnosis, Management, and Prevention of Chronic Obstructive Pulmonary Disease

1 reference

12 December 2020

Plasma thrombomodulin, fibrinogen, and activity of tissue factor as risk factors for acute cerebral infarction

1 reference

12 December 2020

Factor XIa and tissue factor activity in patients with coronary artery disease

1 reference

12 December 2020

Active tissue factor and activated factor XI in circulating blood of patients with systolic heart failure due to ischemic cardiomyopathy

1 reference

12 December 2020

10.1016/J.THROMRES.2010.11.005

Identifiers

DOI

1 reference

3 August 2017

1 reference

3 August 2017

1 reference

PubMed ID

21236471